Literature DB >> 2005917

Stiff-person syndrome: an autoimmune disease.

P Blum1, J Jankovic.   

Abstract

Stiff-person syndrome (SPS) is characterized by progressive, usually symmetric rigidity of the axial muscles with superimposed painful spasms precipitated by tactile stimuli, passive stretch, volitional movement of affected or unaffected muscles, startling noises, and emotional stimuli. Electromyography demonstrates continuous normal motor unit potentials in the affected muscles. Both the rigidity and the spasms are relieved by sleep, general anesthesia, myoneural blockade, peripheral nerve blockade, and partially by diazepam. Evidence for an autoimmune etiology of SPS includes its association with other autoimmune diseases and autoantibodies and the presence of antibodies against glutamic acid decarboxylase (GAD) in the cerebrospinal fluid (CSF) of many affected patients. We describe two patients with this syndrome who had GAD antibodies in both CSF and serum. Partial relief of the symptoms in these patients by corticosteroid therapy provides additional evidence of an autoimmune etiology of SPS and of the role of immunotherapy in its treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2005917     DOI: 10.1002/mds.870060104

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  18 in total

1.  Stiff-man syndrome.

Authors:  H U Rehman
Journal:  Postgrad Med J       Date:  1998-11       Impact factor: 2.401

Review 2.  Stiff muscles.

Authors:  P D Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-02       Impact factor: 10.154

Review 3.  GAD, diabetes, and Stiff-Man syndrome: some progress and more questions.

Authors:  M Solimena; M H Butler; P De Camilli
Journal:  J Endocrinol Invest       Date:  1994 Jul-Aug       Impact factor: 4.256

4.  Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene.

Authors:  D F Bu; M G Erlander; B C Hitz; N J Tillakaratne; D L Kaufman; C B Wagner-McPherson; G A Evans; A J Tobin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

5.  A membrane form of brain L-glutamate decarboxylase: identification, isolation, and its relation to insulin-dependent mellitus.

Authors:  B Nathan; J Bao; C C Hsu; P Aguilar; R Wu; M Yarom; C Y Kuo; J Y Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

6.  Serum glutamate decarboxylase antibodies and neurological disorders: when to suspect their association?

Authors:  Laura Lacruz Ballester; Mireya Fernandez-Fournier; Inmaculada Puertas Muñoz; Olaia Rodriguez Fraga; Clara Lastras Fernandez-Escandon; Francisco Javier Rodriguez de Rivera Garrido; Elda Maria Alba Suarez; Antonio Tallon Barranco
Journal:  Neurol Sci       Date:  2021-04-29       Impact factor: 3.307

Review 7.  GAD antibodies in neurological disorders - insights and challenges.

Authors:  Francesc Graus; Albert Saiz; Josep Dalmau
Journal:  Nat Rev Neurol       Date:  2020-05-26       Impact factor: 42.937

8.  Forty-year-old diabetic lady with tightness in lower limbs.

Authors:  Snehaldatta S Khade; Shrikant S Deshmukh; Pramod V Dhonde; Satish V Khadilkar
Journal:  Ann Indian Acad Neurol       Date:  2012-01       Impact factor: 1.383

9.  Antibodies From Children With PANDAS Bind Specifically to Striatal Cholinergic Interneurons and Alter Their Activity.

Authors:  Jian Xu; Rong-Jian Liu; Shaylyn Fahey; Luciana Frick; James Leckman; Flora Vaccarino; Ronald S Duman; Kyle Williams; Susan Swedo; Christopher Pittenger
Journal:  Am J Psychiatry       Date:  2020-06-16       Impact factor: 18.112

Review 10.  Paraneoplastic neurological syndrome: an evolving story.

Authors:  Jiraporn Jitprapaikulsan; Pritikanta Paul; Smathorn Thakolwiboon; Shivam Om Mittal; Sean J Pittock; Divyanshu Dubey
Journal:  Neurooncol Pract       Date:  2021-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.